Fingerprint
Dive into the research topics of 'Erlotinib and the risk of oral cancer the erlotinib Prevention of Oral Cancer (EPOC) randomized clinical trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
William N. William, Vassiliki Papadimitrakopoulou, J. Jack Lee, Li Mao, Ezra E.W. Cohen, Heather Y. Lin, Ann M. Gillenwater, Jack W. Martin, Mark W. Lingen, Jay O. Boyle, Dong M. Shin, Nadarajah Vigneswaran, Nancy Shinn, John V. Heymach, Ignacio I. Wistuba, Ximing Tang, Edward S. Kim, Pierre Saintigny, Elizabeth A. Blair, Timothy Meiller
Research output: Contribution to journal › Article › peer-review